Meridian Bioscience Inc.

NASDAQ:VIVO  
27.90
+1.58 (+6.00%)
Other Pre-Announcement

Meridian Bioscience Reports Record Second Quarter Fiscal 2022 Operating Results

Published: 05/06/2022 12:26 GMT
Meridian Bioscience Inc. (VIVO) - Meridian Bioscience Reports Record Second Quarter Fiscal 2022 Operating Results.
Sees FY Adjusted Earnings per Share $1.30 to $1.40.
Q2 Revenue Rose 30 Percent to $111.2 Million.
Sees Consolidated FY Net Revenue $330.0 Million to $345.0 Million.
Qtrly Earnings per Share $0.65.
Qtrly Adjusted Earnings per Share $0.66.